Evidence map›Paper›PMID 7690970›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1993

Chimeric tumor necrosis factor-TrkA receptors reveal that ligand-dependent activation of the TrkA tyrosine kinase is sufficient for differentiation and survival of PC12 cells.

G Rovelli, R A Heller, M Canossa, E M Shooter

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 51 citations in OpenAlex.

  1. Glioactive ATP controls BDNF recycling in cortical astrocytes.Communicative & integrative biology · 2017
    Article
  2. Article
  3. Pathophysiological mechanisms for actions of the neurotrophins.Brain pathology (Zurich, Switzerland) · 2006
    Review
  4. Article
  5. Article
  6. Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1997
    Article
  7. Article
  8. Article
  9. Article
  10. Mutational studies of conserved residues in the dimer interface of nerve growth factor.Protein science : a publication of the Protein Society · 1996
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

G RovelliDepartment of Neurobiology, Stanford University School of Medicine, CA 94305-5401.
R A Heller
M Canossa
E M Shooter
Stanford University · US

Funding

THE TRAFFICKING OF MYELIN PROTEINS AND NEUROTROPHINSR01NS004270 · NINDS · STANFORD UNIVERSITY · PI SHOOTER, ERIC M · 1985 to 2003
$2.0M
NINDS NIH HHS NS04270
6 · The paper itself

Abstract

To elucidate the function of the two nerve growth factor (NGF) receptors, p75NGFR and p140trk, chimeric molecules were constructed of tumor necrosis factor (TNF) and NGF receptors. Rat PC12 pheochromocytoma cells transiently transfected with TNF-p140trk chimeras, which contain the extracellular domain of TNF receptor and the transmembrane and cytoplasmic domains of p140trk, showed TNF-dependent neuronal differentiation and cell survival. The activity of TNF-p140trk chimeras was completely blocked by the tyrosine kinase inhibitor K252a, and TNF was unable to induce neurite elongation in PC12 cells transfected with a tyrosine kinase-defective chimeric receptor. The TNF-p75NGFR chimeras, which contain the cytoplasmic domain of p75NGFR, were nonfunctional. Our results suggest that p140trk may function as ligand-activated homodimers and that ligand-mediated activation of the cytoplasmic domain of p140trk alone is sufficient for inducing a neuronal phenotype.

Indexed as

AnimalsCell DifferentiationCell LineCell SurvivalCloning, MolecularDose-Response Relationship, DrugGene ExpressionHumansKineticsNerve Growth FactorsNeuritesPC12 CellsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptors, Cell SurfaceReceptors, Tumor Necrosis FactorNerve Growth FactorsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptors, Cell SurfaceReceptors, Tumor Necrosis FactorReceptor, trkARecombinant Fusion ProteinsRecombinant ProteinsRNATumor Necrosis Factor-alpha

Identifiers

PMID7690970
PMCPMC47429
OpenAlexW2002875788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.